Veronica Ridpath, DO, Psych Congress Elevate faculty member, discusses how evolving understanding of the biological pathways involved in depression is changing the landscape of treatment approaches.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in depression treatment.
In part 2 of this Q and A, Brittany Albright, MD, MPH, founder and CEO of Sweetgrass Psychiatry, discusses 2 of her favorite strategies for treating patients who have anhedonia.
In this Q&A, Dr Brittany Albright sheds light on the pervasive and challenging symptom of anhedonia, which can have profound implications on patients’ quality of life, clinical outcomes, and societal...
In this video, Bin Huang, DrPH, discusses his team's study, which used data from the Kentucky Cancer Registry to assess the influence of depression on breast cancer treatment and survival, what he found...
